Reply: To PMID 25577672

Am J Obstet Gynecol. 2015 Dec;213(6):881. doi: 10.1016/j.ajog.2015.08.029. Epub 2015 Aug 17.

Authors

Alessandro D Santin¹, Dana M Roque²

Affiliations

¹ Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT. Electronic address: alessandro.santin@yale.edu.
² Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD.

PMID: 26292047
DOI: 10.1016/j.ajog.2015.08.029

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Ferric Compounds / therapeutic use*
Hemostatics / therapeutic use*
Humans
Postpartum Hemorrhage / drug therapy*
Pregnancy
Sulfates / therapeutic use*

Substances

Ferric Compounds
Hemostatics
Sulfates